Global Mecobalamin (Methylcobalamin) API Market Research Report 2024

Publication ID:

PB506246628

Publication Date:

June 18, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Methylcobalamin (mecobalamin, MeCbl, or MeB12) is a cobalamin, a form of vitamin B12. It differs from cyanocobalamin in that the cyano group at the cobalt is replaced with a methyl group. Methylcobalamin features an octahedral cobalt(III) centre and can be obtained as bright red crystals.
The global Mecobalamin (Methylcobalamin) API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Mecobalamin (Methylcobalamin) API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Mecobalamin (Methylcobalamin) API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Mecobalamin (Methylcobalamin) API include EUROAPI, Eisai Co., Ltd, HTBA, Cspc Holdings Company, Ningxia Kingvit Pharmaceutical, Yufeng Industry Group, North China Pharmaceutical Company, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mecobalamin (Methylcobalamin) API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mecobalamin (Methylcobalamin) API.
The Mecobalamin (Methylcobalamin) API market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Mecobalamin (Methylcobalamin) API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mecobalamin (Methylcobalamin) API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
EUROAPI
Eisai Co., Ltd
HTBA
Cspc Holdings Company
Ningxia Kingvit Pharmaceutical
Yufeng Industry Group
North China Pharmaceutical Company
Segment by Type
Purity 鈮�99%
Purity <99%
Segment by Application
Oral Formulation
Injectable Formulation
Sprays
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mecobalamin (Methylcobalamin) API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mecobalamin (Methylcobalamin) API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Mecobalamin (Methylcobalamin) API Market Overview
1.1 Product Definition
1.2 Mecobalamin (Methylcobalamin) API by Type
1.2.1 Global Mecobalamin (Methylcobalamin) API Market Value Comparison by Type (2024-2030)
1.2.2 Purity 鈮�99%
1.2.3 Purity <99%
1.3 Mecobalamin (Methylcobalamin) API by Application
1.3.1 Global Mecobalamin (Methylcobalamin) API Market Value by Application (2024-2030)
1.3.2 Oral Formulation
1.3.3 Injectable Formulation
1.3.4 Sprays
1.4 Global Mecobalamin (Methylcobalamin) API Market Size Estimates and Forecasts
1.4.1 Global Mecobalamin (Methylcobalamin) API Revenue 2019-2030
1.4.2 Global Mecobalamin (Methylcobalamin) API Sales 2019-2030
1.4.3 Global Mecobalamin (Methylcobalamin) API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Mecobalamin (Methylcobalamin) API Market Competition by Manufacturers
2.1 Global Mecobalamin (Methylcobalamin) API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Mecobalamin (Methylcobalamin) API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Mecobalamin (Methylcobalamin) API Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Mecobalamin (Methylcobalamin) API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mecobalamin (Methylcobalamin) API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mecobalamin (Methylcobalamin) API, Product Type & Application
2.7 Global Key Manufacturers of Mecobalamin (Methylcobalamin) API, Date of Enter into This Industry
2.8 Global Mecobalamin (Methylcobalamin) API Market Competitive Situation and Trends
2.8.1 Global Mecobalamin (Methylcobalamin) API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mecobalamin (Methylcobalamin) API Players Market Share by Revenue
2.8.3 Global Mecobalamin (Methylcobalamin) API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mecobalamin (Methylcobalamin) API Market Scenario by Region
3.1 Global Mecobalamin (Methylcobalamin) API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Mecobalamin (Methylcobalamin) API Sales by Region: 2019-2030
3.2.1 Global Mecobalamin (Methylcobalamin) API Sales by Region: 2019-2024
3.2.2 Global Mecobalamin (Methylcobalamin) API Sales by Region: 2025-2030
3.3 Global Mecobalamin (Methylcobalamin) API Revenue by Region: 2019-2030
3.3.1 Global Mecobalamin (Methylcobalamin) API Revenue by Region: 2019-2024
3.3.2 Global Mecobalamin (Methylcobalamin) API Revenue by Region: 2025-2030
3.4 North America Mecobalamin (Methylcobalamin) API Market Facts & Figures by Country
3.4.1 North America Mecobalamin (Methylcobalamin) API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Mecobalamin (Methylcobalamin) API Sales by Country (2019-2030)
3.4.3 North America Mecobalamin (Methylcobalamin) API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mecobalamin (Methylcobalamin) API Market Facts & Figures by Country
3.5.1 Europe Mecobalamin (Methylcobalamin) API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Mecobalamin (Methylcobalamin) API Sales by Country (2019-2030)
3.5.3 Europe Mecobalamin (Methylcobalamin) API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mecobalamin (Methylcobalamin) API Market Facts & Figures by Region
3.6.1 Asia Pacific Mecobalamin (Methylcobalamin) API Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Mecobalamin (Methylcobalamin) API Sales by Region (2019-2030)
3.6.3 Asia Pacific Mecobalamin (Methylcobalamin) API Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mecobalamin (Methylcobalamin) API Market Facts & Figures by Country
3.7.1 Latin America Mecobalamin (Methylcobalamin) API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Mecobalamin (Methylcobalamin) API Sales by Country (2019-2030)
3.7.3 Latin America Mecobalamin (Methylcobalamin) API Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mecobalamin (Methylcobalamin) API Market Facts & Figures by Country
3.8.1 Middle East and Africa Mecobalamin (Methylcobalamin) API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Mecobalamin (Methylcobalamin) API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Mecobalamin (Methylcobalamin) API Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mecobalamin (Methylcobalamin) API Sales by Type (2019-2030)
4.1.1 Global Mecobalamin (Methylcobalamin) API Sales by Type (2019-2024)
4.1.2 Global Mecobalamin (Methylcobalamin) API Sales by Type (2025-2030)
4.1.3 Global Mecobalamin (Methylcobalamin) API Sales Market Share by Type (2019-2030)
4.2 Global Mecobalamin (Methylcobalamin) API Revenue by Type (2019-2030)
4.2.1 Global Mecobalamin (Methylcobalamin) API Revenue by Type (2019-2024)
4.2.2 Global Mecobalamin (Methylcobalamin) API Revenue by Type (2025-2030)
4.2.3 Global Mecobalamin (Methylcobalamin) API Revenue Market Share by Type (2019-2030)
4.3 Global Mecobalamin (Methylcobalamin) API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Mecobalamin (Methylcobalamin) API Sales by Application (2019-2030)
5.1.1 Global Mecobalamin (Methylcobalamin) API Sales by Application (2019-2024)
5.1.2 Global Mecobalamin (Methylcobalamin) API Sales by Application (2025-2030)
5.1.3 Global Mecobalamin (Methylcobalamin) API Sales Market Share by Application (2019-2030)
5.2 Global Mecobalamin (Methylcobalamin) API Revenue by Application (2019-2030)
5.2.1 Global Mecobalamin (Methylcobalamin) API Revenue by Application (2019-2024)
5.2.2 Global Mecobalamin (Methylcobalamin) API Revenue by Application (2025-2030)
5.2.3 Global Mecobalamin (Methylcobalamin) API Revenue Market Share by Application (2019-2030)
5.3 Global Mecobalamin (Methylcobalamin) API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 EUROAPI
6.1.1 EUROAPI Company Information
6.1.2 EUROAPI Description and Business Overview
6.1.3 EUROAPI Mecobalamin (Methylcobalamin) API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 EUROAPI Mecobalamin (Methylcobalamin) API Product Portfolio
6.1.5 EUROAPI Recent Developments/Updates
6.2 Eisai Co., Ltd
6.2.1 Eisai Co., Ltd Company Information
6.2.2 Eisai Co., Ltd Description and Business Overview
6.2.3 Eisai Co., Ltd Mecobalamin (Methylcobalamin) API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eisai Co., Ltd Mecobalamin (Methylcobalamin) API Product Portfolio
6.2.5 Eisai Co., Ltd Recent Developments/Updates
6.3 HTBA
6.3.1 HTBA Company Information
6.3.2 HTBA Description and Business Overview
6.3.3 HTBA Mecobalamin (Methylcobalamin) API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 HTBA Mecobalamin (Methylcobalamin) API Product Portfolio
6.3.5 HTBA Recent Developments/Updates
6.4 Cspc Holdings Company
6.4.1 Cspc Holdings Company Company Information
6.4.2 Cspc Holdings Company Description and Business Overview
6.4.3 Cspc Holdings Company Mecobalamin (Methylcobalamin) API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cspc Holdings Company Mecobalamin (Methylcobalamin) API Product Portfolio
6.4.5 Cspc Holdings Company Recent Developments/Updates
6.5 Ningxia Kingvit Pharmaceutical
6.5.1 Ningxia Kingvit Pharmaceutical Company Information
6.5.2 Ningxia Kingvit Pharmaceutical Description and Business Overview
6.5.3 Ningxia Kingvit Pharmaceutical Mecobalamin (Methylcobalamin) API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ningxia Kingvit Pharmaceutical Mecobalamin (Methylcobalamin) API Product Portfolio
6.5.5 Ningxia Kingvit Pharmaceutical Recent Developments/Updates
6.6 Yufeng Industry Group
6.6.1 Yufeng Industry Group Company Information
6.6.2 Yufeng Industry Group Description and Business Overview
6.6.3 Yufeng Industry Group Mecobalamin (Methylcobalamin) API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Yufeng Industry Group Mecobalamin (Methylcobalamin) API Product Portfolio
6.6.5 Yufeng Industry Group Recent Developments/Updates
6.7 North China Pharmaceutical Company
6.7.1 North China Pharmaceutical Company Company Information
6.7.2 North China Pharmaceutical Company Description and Business Overview
6.7.3 North China Pharmaceutical Company Mecobalamin (Methylcobalamin) API Sales, Revenue and Gross Margin (2019-2024)
6.7.4 North China Pharmaceutical Company Mecobalamin (Methylcobalamin) API Product Portfolio
6.7.5 North China Pharmaceutical Company Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mecobalamin (Methylcobalamin) API Industry Chain Analysis
7.2 Mecobalamin (Methylcobalamin) API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mecobalamin (Methylcobalamin) API Production Mode & Process
7.4 Mecobalamin (Methylcobalamin) API Sales and Marketing
7.4.1 Mecobalamin (Methylcobalamin) API Sales Channels
7.4.2 Mecobalamin (Methylcobalamin) API Distributors
7.5 Mecobalamin (Methylcobalamin) API Customers
8 Mecobalamin (Methylcobalamin) API Market Dynamics
8.1 Mecobalamin (Methylcobalamin) API Industry Trends
8.2 Mecobalamin (Methylcobalamin) API Market Drivers
8.3 Mecobalamin (Methylcobalamin) API Market Challenges
8.4 Mecobalamin (Methylcobalamin) API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

EUROAPI
Eisai Co., Ltd
HTBA
Cspc Holdings Company
Ningxia Kingvit Pharmaceutical
Yufeng Industry Group
North China Pharmaceutical Company

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂